Sign in

CIK 0001516551

  • Non-accelerated filer
  • Smaller reporting company

Skye Bioscience, Inc.

Sign in to watch
Ticker
SKYE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
450692882
Phone
+1 858-410-0266
Business address
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO, CA, 92130
Former names
Emerald Bioscience, Inc., Nemus Bioscience, Inc., LOAD GUARD LOGISTICS, INC., LOAD GUARD TRANSPORTATION, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$613,506
in 6 filings

Net −$613,506. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-06 Twitty Christopher Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000
2026-02-06 Charych Deborah H. Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2026-02-06 Jenkins Annalisa Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2026-02-06 Diep Tuan Tu Chief Development Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2026-02-06 Arora Puneet S. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +125,000 125,000
2026-02-06 DHILLON PUNIT Chief Executive Officer Grant or award · Stock Option (Right to Buy) +280,000 280,000
2025-08-22 Schwab Andrew J. Director Sale −163,979 $3.42 $561K 1,457,064
2025-08-22 Schwab Andrew J. Director Sale −6,470 $3.42 $22K 57,493
2025-08-22 5AM Partners VII, LLC 10% owner Sale −163,979 $3.42 $561K 1,457,064
2025-08-22 5AM Partners VII, LLC 10% owner Sale −6,470 $3.42 $22K 57,493
2025-08-21 Schwab Andrew J. Director Sale −58,642 $3.57 $209K 1,621,043
2025-08-21 Schwab Andrew J. Director Sale −2,314 $3.57 $8K 63,963
2025-08-21 5AM Partners VII, LLC 10% owner Sale −58,642 $3.57 $209K 1,621,043
2025-08-21 5AM Partners VII, LLC 10% owner Sale −2,314 $3.57 $8K 63,963
2025-02-24 Schwab Andrew J. Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2025-02-24 ARSENAULT KAITLYN Chief Financial Officer Grant or award · Stock Option (Right to Buy) +150,000 150,000
2025-02-24 Jenkins Annalisa Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2025-02-24 Grayson Paul A. Director Grant or award · Stock Option (Right to Buy) +135,000 135,000
2025-02-24 Smith Karen L. Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2025-02-24 DHILLON PUNIT Chief Executive Officer Grant or award · Stock Option (Right to Buy) +250,000 250,000

Page 5 of 15 · 292 trades